Health Effects & Risks of Kratom, Opioids & Other Natural Occurring Medicines | Dr. Chris McCurdy

概览

This episode features Andrew Huberman in conversation with Dr. Chris McCurdy, a medicinal chemist whose work focuses on natural products, especially kratom. The central question is not simply whether kratom is “good” or “bad,” but how its risks and potential benefits depend on the product form, dose, user population, and reason for use.

A major theme is the distinction between traditional kratom leaf use and many modern U.S. products. McCurdy explains that fresh leaves or leaf teas differ sharply from extracts, concentrates, isolates, and semisynthetic kratom-derived compounds, especially products involving 7-hydroxymitragynine.

The discussion broadens into natural-product pharmacology: alkaloids, opioids, coca leaf, cacao, soft drinks, and the history of medicines derived from plants. The episode repeatedly returns to a practical public-health message: serving size, product type, age, dependence risk, drug interactions, and medical supervision matter.

分段落总结

[00:00] Episode Setup and Why Kratom Matters

[事实] Huberman introduces Dr. Chris McCurdy as a professor of medicinal chemistry at the University of Florida who studies natural products and their pharmacologic effects.

[事实] The episode focuses on kratom, its relationship to opioid systems, its potential for addiction, and the differences between traditional leaf products and modern extracts or isolates.

[事实] Huberman says kratom products are now widely available in supermarkets, convenience stores, and online, often marketed for energy, pain management, or mood.

[推测] The episode frames kratom as a public-health issue because many consumers may encounter it before understanding what type of product they are using.

[03:49] What Kratom Is and How It Is Traditionally Used

[事实] McCurdy identifies kratom as Mitragyna speciosa, a tree native to the region where Peninsular Malaysia and Thailand meet.

[事实] In traditional Southeast Asian use, laborers chew fresh leaves or boil them into a tea-like decoction for energy, stamina, pain relief, mood elevation, and social use.

[事实] McCurdy says lower amounts are associated with stimulant-like effects, while higher consumption can become more euphoric or sedative and opioid-like.

[事实] Traditional users have also reportedly used kratom to reduce withdrawal when heroin or raw opium was unavailable.

[10:21] Traditional Leaf Versus U.S. Extract Products

[事实] McCurdy says U.S. and Western kratom products usually begin as dried leaf material shipped from Indonesia, not fresh leaves used the same day.

[事实] Powdered leaf, capsules, extracts, concentrates, and tonics differ because liquids or solvents can pre-extract active compounds before ingestion.

[事实] He explains that water is an inefficient extractor, while concentrated products can deliver compounds faster and at higher exposure.

[推测] This distinction implies that “kratom” is too broad a label unless the product form and processing method are specified.

[15:00] Serving Size, Concentration, and Consumer Risk

[事实] McCurdy compares lower-risk leaf-like products to light beer or seltzers and highly concentrated isolates to very strong alcohol.

[事实] He says many products may contain multiple servings in a small bottle, and consumers may drink the whole bottle without reading the serving information.

[事实] Huberman emphasizes that users need to check serving size and distinguish kratom leaf products from kratom-derived or extracted products.

[推测] Small packaging and fine-print serving labels may make accidental overconsumption more likely.

[20:00] Semisynthetic Products and Delayed Effects

[事实] McCurdy warns that some products called kratom-derived are chemically modified and may no longer be traceable to the plant in a traditional sense.

[事实] He says concentrated products can create a delayed effect, where a person takes more before the first dose fully hits.

[事实] He gives the example of kratom energy shots sold near ordinary energy shots, raising concern that people, including young people, may misunderstand what they are buying.

[推测] The danger is not only kratom exposure itself, but the mismatch between consumer expectations and pharmacologic reality.

[25:23] Who Uses Kratom and Why

[事实] McCurdy says published estimates suggested around two to two-and-a-half million U.S. users, while sales and import estimates suggest more than 20 million daily users.

[事实] He cites 2019 data of 1,950 metric tons per month coming into the United States.

[事实] Based on ecological momentary assessment studies, McCurdy says many users report using kratom for energy, mood elevation, and pain treatment rather than to get high.

[事实] Some users report using kratom as a pre-workout stimulant or post-workout pain-relief aid.

[30:52] Dependence, Tolerance, and User Categories

[事实] McCurdy says kratom can cause physical dependence, though the timeline and dose relationship are not well defined in chronic human studies.

[事实] He compares some leaf-product withdrawal reports to caffeine withdrawal, including headache and feeling unwell, while other reports include more opioid-like symptoms such as restless legs.

[事实] Huberman summarizes three use patterns: caffeine-like stimulant use, higher-dose euphoric or sedative use, and use for reducing or replacing opioids.

[推测] Kratom dependence may vary substantially depending on product type, dose, frequency, and the user’s initial reason for taking it.

[37:55] Alkaloids and How Plant Molecules Act in the Body

[事实] McCurdy explains that kratom contains many alkaloids, and defines an alkaloid as an organic molecule containing nitrogen.

[事实] Examples discussed include caffeine, cocaine, morphine, nicotine, dopamine, and serotonin.

[事实] He explains that charged nitrogen atoms can help molecules interact with proteins and receptors in the body.

[事实] Nicotine is used as an example of a plant alkaloid that helped define nicotinic acetylcholine receptors.

[50:00] Natural Products, Medicine, and Lost Context

[事实] Huberman contrasts traditional plant familiarity with modern product purchase and immediate ingestion.

[事实] McCurdy says roughly 75% of available FDA-approved medications were discovered because of natural products or modified natural products.

[事实] Examples discussed include aspirin from willow bark, metformin-like effects from berberine, and GLP-1 drugs connected to Gila monster saliva research.

[推测] The conversation suggests that modern medicine often gains power by isolating compounds, but may lose context about dose, source, and whole-plant complexity.

[60:43] Morphine, Cocaine, and the Cautionary Tale for Kratom

[事实] McCurdy says morphine was the first alkaloid isolated and that cocaine was the second.

[事实] He explains that coca leaf has long-standing traditional use in South America, while isolated cocaine became the focus of criminalization and public-health harm.

[事实] He says kratom may face a similar problem as compounds from the plant are isolated, modified, and sold as potent products.

[事实] The compound 7-hydroxymitragynine is described as a metabolite of mitragynine and as a product now being chemically produced and sold.

[64:51] 7-Hydroxymitragynine and Kratom-Derived Products

[事实] McCurdy says his group has not found enzymes in the plant that would produce 7-hydroxymitragynine, while the body can produce it as a metabolite.

[事实] He says 7-hydroxymitragynine acts as a pure opioid in its activity and interacts with opioid receptors.

[事实] Huberman and McCurdy emphasize that consumers and clinicians should distinguish leaf kratom, extracts, concentrates, isolates, and kratom-derived products.

[推测] The episode treats 7-hydroxymitragynine products as a distinct risk category rather than as ordinary kratom.

[69:18] Age, Developing Brains, and Lower-Dose Adult Use

[事实] McCurdy says he is not familiar with traditional young-person use in Southeast Asia and describes traditional use as mainly adult laborer use.

[事实] He supports age restrictions such as 18 or 21 and says the brain continues developing until around 24 or 25.

[事实] For adult leaf-product users, he says many report that “less is more” and that lower amounts seem to provide more benefit.

[事实] He says tolerance can develop to pain-relieving effects, which may lead people to take more.

[推测] The episode’s practical stance is that young people should avoid kratom, and adults should be cautious about dose escalation.

[76:43] Respiratory Depression and Naloxone Reversal

[事实] McCurdy says kratom as a whole has not been adequately studied for respiratory depression.

[事实] He says it has long been anecdotally claimed that kratom causes less respiratory depression than clinical or illicit opioids, but this is not scientifically definitive.

[事实] He says 7-hydroxymitragynine products caused respiratory depression equivalent to opioids in rat studies.

[事实] He says the effect in animals was reversible with Narcan or naloxone, indicating opioid receptor involvement.

[84:00] Regulation, Advocacy, and FDA Loopholes

[事实] McCurdy explains that under FDA dietary ingredient rules, a metabolite of a dietary ingredient can also be considered a dietary ingredient.

[事实] He names advocacy groups that support science-based guidelines, labeling, serving-size limits, and alkaloid-content guardrails.

[事实] He also mentions a group advocating for 7-hydroxymitragynine products as harm reduction, while saying he has not seen solid evidence for that claim.

[推测] Regulatory uncertainty allows very different products to coexist under similar consumer-facing language.

[87:00] Alcohol, Aphrodisiac Claims, and Unknown Interactions

[事实] McCurdy says studies combining kratom and alcohol have not been done in the way needed to clearly answer respiratory-risk questions.

[事实] He says kratom has been anecdotally reported to reduce alcohol intake, and that researchers are studying kratom as a possible harm-reduction agent for alcohol use disorder.

[事实] He says the aphrodisiac claim is not clearly tied to Viagra-like phosphodiesterase pathways and may relate more to stimulant or stamina effects.

[推测] The alcohol and aphrodisiac discussions show how many kratom claims remain plausible but under-tested.

[90:00] Kratom’s Multiple Pharmacologic Pathways

[事实] McCurdy says mitragynine is the major kratom alkaloid but does not equal kratom as a whole.

[事实] He says mitragynine has weak affinity for opioid receptors and does not do much by itself from an analgesia perspective.

[事实] Other kratom alkaloids interact with serotonergic and adrenergic systems, both of which are involved in mood, stimulation, and pain processing.

[事实] McCurdy describes kratom as acting through at least opioid, serotonergic, and adrenergic pathways.

[推测] Whole-leaf kratom may feel different from isolated compounds because it engages several systems at once.

[98:41] Why the Kratom Plant Produces These Compounds

[事实] McCurdy says his team at the University of Florida works with plant scientists to understand why kratom produces its chemicals.

[事实] He says the plant likely produces these compounds for defense, especially against fungus in hot, humid, swampy environments.

[事实] His group has not seen activity against human pathogenic fungi so far, but has seen activity against agriculturally relevant fungi.

[推测] The plant’s benefit to humans is incidental rather than the reason the plant evolved these compounds.

[105:01] White, Red, Brown, Green, and Yellow Vein Claims

[事实] McCurdy says white vein, red vein, brown vein, green vein, and yellow vein distinctions are mostly marketing.

[事实] He explains that color often reflects drying, curing, sun exposure, cold damage, or leaf-processing conditions.

[事实] His group’s alkaloid analyses found different colors and strains to be very similar in alkaloid content.

[事实] He adds that other non-alkaloid chemical changes have not been fully studied.

[推测] Reported differences between vein colors may come from product source, processing, expectations, or non-alkaloid chemistry rather than clear alkaloid differences.

[111:00] Mood Effects and Antidepressant Potential

[事实] McCurdy says the mood-elevation and well-being reports around kratom are anecdotal but may represent a signal worth studying.

[事实] He says proper controlled human clinical trials are needed to determine whether kratom has true antidepressant benefit.

[推测] The episode treats antidepressant use as an open research question, not an established recommendation.

[112:15] Getting Off Kratom

[事实] McCurdy says there is no clear established answer for how to get off kratom.

[事实] Addiction physicians have used buprenorphine, Suboxone, or methadone because kratom has opioid-like properties.

[事实] McCurdy cautions that kratom also affects serotonergic and adrenergic systems, so opioid-only treatment may not address every aspect of dependence.

[事实] He recommends medical professional help rather than trying to manage serious kratom dependence alone.

[119:15] Drug Interactions and a Seizure Case Report

[事实] McCurdy describes a 2008 case report involving leaf kratom, modafinil, and a full seizure.

[事实] The patient had reportedly used kratom to quit Dilaudid cold turkey and later quit kratom after the seizure, reporting only a runny nose and no desire to return.

[事实] Huberman describes the case as showing the precariousness of at-home polypharmacology.

[推测] The case is informative but cannot establish a general rule because it is a single case.

[123:00] Cacao, Theobromine, and Reward

[事实] Huberman asks about cacao, cocoa, 100% chocolate, and raw cacao beans.

[事实] McCurdy says cacao contains theobromine, a xanthine alkaloid related to caffeine.

[事实] Theobromine is described as stimulant-like and as having respiratory effects similar to older asthma-related xanthine drugs.

[事实] They discuss cacao’s mild reward effects, polyphenols, and the importance of ethically sourced cacao.

[推测] Cacao is presented as a gentler example of plant pharmacology compared with highly addictive isolated drugs.

[129:00] Coca-Cola, Coca Leaf, and Early Soft Drinks

[事实] McCurdy says Coca-Cola originally contained coca leaf extract and kola nut extract and was sold as a tonic.

[事实] He says early soft drinks often had pharmacologic origins, including 7-Up with lithium, Pepsi with pepsin, and Dr. Pepper as a wellness formula.

[事实] He says Coca-Cola originally contained cocaine, but later removed cocaine while retaining de-alkalinated coca leaf extract for flavor.

[事实] He says Coca-Cola remains connected to coca leaf importation through processing that separates cocaine alkaloids for pharmaceutical use from the flavoring extract.

[135:00] Coca Extract, GI Effects, and Lithium in 7-Up

[事实] McCurdy says the remaining coca-derived flavoring in Coca-Cola is probably not psychoactive.

[事实] He says Coke syrup was formerly sold in pharmacies for nausea and vomiting, including in pregnant women.

[事实] He says coca tea users report GI-calming effects, and that similar GI effects may remain in the de-alkalinated extract.

[事实] He says lithium is no longer in 7-Up.

[140:22] McCurdy’s Background and Path Into Medicinal Chemistry

[事实] McCurdy says his father was a pharmacist and his mother later became a comprehensive science teacher.

[事实] He describes a high-school chemistry project in which he measured caffeine in beverages and extracted caffeine from Vivarin tablets.

[事实] He studied pharmacy, entered a medicinal chemistry lab, and was encouraged by a mentor to pursue research.

[事实] He completed pharmacy training, went to graduate school at the University of Georgia, and practiced pharmacy while doing his PhD.

[147:43] From Lobeline and Opioids to Kratom Research

[事实] McCurdy’s PhD work involved analogs of lobeline, a compound from Lobelia inflata, studied in relation to cholinergic systems and Alzheimer’s hypotheses.

[事实] He later trained in opioid chemistry at the University of Minnesota and worked at the University of Mississippi, where natural-products research was central.

[事实] He studied salvia divinorum and salvinorin A, a potent hallucinogenic compound acting at kappa opioid receptors.

[事实] A NIDA invitation to speak on naturally occurring pain substances led him to Mitragyna speciosa and prior SmithKline research on mitragynine.

[154:41] Closing Takeaways on Nuance and Public Education

[事实] McCurdy says SmithKline studied mitragynine decades earlier and found it comparable to codeine, but did not develop it further.

[事实] Huberman highlights key takeaways: serving size, product category, intended use, kratom-derived products, isolates, drug interactions, and the need to avoid simplistic “good” or “bad” labels.

[事实] McCurdy closes by saying there may be benefits, risks, and potential harms, and that public education is needed to understand where each lies.

[推测] The episode’s strongest message is that kratom policy and personal decisions should be based on product-specific pharmacology rather than broad claims.

播客点评/总结

This episode is valuable because it avoids a binary treatment of kratom. McCurdy repeatedly separates traditional leaf use, powdered leaf, extracts, concentrates, isolates, and semisynthetic products, which makes the conversation more useful than a simple warning or endorsement.

Its main strength is the connection between chemistry and public health. The discussion explains why serving size, formulation, age, tolerance, respiratory depression, drug interactions, and withdrawal treatment all matter. It also gives broader context through morphine, cocaine, cacao, and the pharmacologic history of soft drinks.

The limitation is that many claims remain based on anecdote, animal work, survey data, or still-developing research. The transcript itself makes this clear: chronic human studies, alcohol-combination data, antidepressant trials, and kratom-discontinuation protocols are not yet definitive.

[推测] This episode is best suited for listeners interested in kratom, addiction science, pain treatment, natural products, medicinal chemistry, or supplement regulation. It is less suitable as a direct personal-use protocol, because the speakers repeatedly stress uncertainty, product variability, and the need for medical guidance in dependence or drug-interaction scenarios.